Novo Nordisk stock climbs out of hole on FDA chief’s threat to block Hims and Hers pill


Novo Nordisk shares rallied on Friday in what’s still been a painful week as the Food and Drug Administration may weigh in on the side of the Danish drugmaker in its dispute over a copycat drug.

You May Also Like

American Airlines’ stock could gain as much as 38%, say analysts in new upgrade

Raymond James is positive on an improved revenue outlook, a card agreement…

U.S. stocks got clobbered Friday despite a blockbuster jobs report. What’s going on?

Rising bond yields are heaping pressure on equities as investors fear a…

Citadel’s Ken Griffin: Fed must go slow on rate cuts to avoid disaster

Citadel’s Ken Griffin warns that a Fed policy flip-flop would be the…

Cathay General Bancorp gets fresh $125 million buyback program

Cathay General Bancorp said its board had adopted a new $125 million…